Eliminate Coronary Artery Disease

NCT02245087 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped Lack of Funding

Conditions

Coronary Artery Disease

Interventions

DRUG: Atorvastatin

Sponsor

University Health Network, Toronto